News Zhejiang Jolly Pharmaceutical Co.,LTD

Equities

300181

CNE100001096

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
14.54 ^CNY	-0.55%		+8.91%	+36.40%

Apr. 18	Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 18	CI
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-22	CI
Zhejiang Jolly Pharmaceutical Co.,LTD(XSEC:300181) added to S&P Global BMI Index	23-09-18	CI
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-08	CI
Zhejiang Jolly Pharmaceutical Co.,LTD Announces Cash Dividend on A Shares for the Year 2022, Payable on 30 May 2023	23-05-24	CI
Zhejiang Jolly Pharmaceutical Co.,LTD Approves Cash Dividend for 2022	23-05-22	CI
Zhejiang Jolly Pharmaceutical Co.,LTD Proposes Final Cash Dividend for the Year 2022	23-04-26	CI
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-24	CI
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Zhejiang Jolly Pharmaceutical Co.,LTD signed an equity transfer agreement to acquire the remaining 48.99% stake in Zhejiang Jolly Baicao Chinese Medicine Decoction Pieces Co., Ltd. from Chen Huan and Chen Zhaorong for RMB 75 million.	22-08-14	CI
Zhejiang Jolly Pharmaceutical Co.,LTD Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on 31 May 2022	22-05-25	CI
Zhejiang Jolly Pharmaceutical Co.,LTD completed the acquisition of 8% stake in Zhejiang Top Medicine Co.,Ltd. from Yu Yin.	22-05-16	CI
Zhejiang Jolly Pharmaceutical Co.,Ltd Approves Cash Dividend for 2021	22-05-13	CI
Zhejiang Jolly Pharmaceutical Co.,LTD Proposes Cash Dividend for 2021	22-04-20	CI
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-19	CI
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-09	CI
Zhejiang Jolly Pharmaceutical Co.,LTD announced that it expects to receive CNY 910 million in funding	22-01-25	CI
Zhejiang Jolly Pharmaceutical Co.,LTD agreed to acquire 8% stake in Zhejiang Top Medicine Co.,Ltd. from Yu Yin for CNY 10.7 million.	21-12-27	CI
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Zhejiang Jolly Pharmaceutical Co.,LTD

Equities

300181

CNE100001096

Summary

Filters